Jacqueline Roseleur1, Gillian Harvey2, Nigel Stocks3, Jonathan Karnon4,5. 1. School of Public Health, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia. jackie.roseleur@adelaide.edu.au. 2. Adelaide Nursing School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia. 3. Discipline of General Practice, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia. 4. School of Public Health, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia. 5. College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Abstract
BACKGROUND AND OBJECTIVE: Medication adherence is poor in patients with chronic conditions. Behavioral economic interventions may reduce biases that are associated with poor adherence. The objective of this review is to map the available evidence on behavioral economic interventions to improve medication adherence in adults with chronic conditions in high-income settings. METHODS: We conducted a scoping review and reported the study using the Joanna Briggs Institute Reviewers' Manual and the PRISMA Extension for Scoping Review checklist. We searched PubMed, EMBASE, SCOPUS, PsycINFO, EconLit, and CINAHL from database inception to 29 August, 2018 for peer-reviewed studies and included a search of the gray literature. Data on study characteristics, study design, and study outcomes were extracted by one reviewer. Twenty-five percent of the studies were verified by a second reviewer. RESULTS: Thirty-four studies, targeting diabetes mellitus, human immunodeficiency virus, and cardiovascular and renal diseases met our inclusion criteria. All but two studies were from the USA. The majority of interventions used financial incentives, often in conjunction with other behavioral economic concepts. Non-financial interventions included framing, social influences, reinforcement, and feedback. The effectiveness of interventions was mixed. CONCLUSIONS: Behavioral economic informed interventions show promise in terms of improving medication adherence. However, there is no single simple intervention. This review highlighted the importance of targeting non-adherent patients, understanding their reasons for non-adherence, providing reminders and feedback to patients and physicians, and measuring clinical outcomes in addition to medication adherence. Further research in settings that differ from the US health system is needed.
BACKGROUND AND OBJECTIVE: Medication adherence is poor in patients with chronic conditions. Behavioral economic interventions may reduce biases that are associated with poor adherence. The objective of this review is to map the available evidence on behavioral economic interventions to improve medication adherence in adults with chronic conditions in high-income settings. METHODS: We conducted a scoping review and reported the study using the Joanna Briggs Institute Reviewers' Manual and the PRISMA Extension for Scoping Review checklist. We searched PubMed, EMBASE, SCOPUS, PsycINFO, EconLit, and CINAHL from database inception to 29 August, 2018 for peer-reviewed studies and included a search of the gray literature. Data on study characteristics, study design, and study outcomes were extracted by one reviewer. Twenty-five percent of the studies were verified by a second reviewer. RESULTS: Thirty-four studies, targeting diabetes mellitus, human immunodeficiency virus, and cardiovascular and renal diseases met our inclusion criteria. All but two studies were from the USA. The majority of interventions used financial incentives, often in conjunction with other behavioral economic concepts. Non-financial interventions included framing, social influences, reinforcement, and feedback. The effectiveness of interventions was mixed. CONCLUSIONS: Behavioral economic informed interventions show promise in terms of improving medication adherence. However, there is no single simple intervention. This review highlighted the importance of targeting non-adherent patients, understanding their reasons for non-adherence, providing reminders and feedback to patients and physicians, and measuring clinical outcomes in addition to medication adherence. Further research in settings that differ from the US health system is needed.
Authors: Marc I Rosen; Kevin Dieckhaus; Thomas J McMahon; Barbara Valdes; Nancy M Petry; Joyce Cramer; Bruce Rounsaville Journal: AIDS Patient Care STDS Date: 2007-01 Impact factor: 5.078
Authors: Marjan Javanbakht; Paul Prosser; Tim Grimes; Michael Weinstein; Charles Farthing Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2006-12
Authors: Marcella Alsan; John Beshears; Wendy S Armstrong; James J Choi; Brigitte C Madrian; Minh Ly T Nguyen; Carlos Del Rio; David Laibson; Vincent C Marconi Journal: AIDS Date: 2017-07-31 Impact factor: 4.177
Authors: Kimberly B Garza; Justin K Owensby; Kimberly Braxton Lloyd; Elizabeth A Wood; Richard A Hansen Journal: Ann Pharmacother Date: 2015-10-06 Impact factor: 3.154
Authors: Peter P Reese; Judd B Kessler; Jalpa A Doshi; Joelle Friedman; Adam S Mussell; Caroline Carney; Jingsan Zhu; Wenli Wang; Andrea Troxel; Peinie Young; Victor Lawnicki; Swapnil Rajpathak; Kevin Volpp Journal: J Gen Intern Med Date: 2016-04 Impact factor: 5.128
Authors: Tatiana M Davidson; John McGillicuddy; Martina Mueller; Brenda Brunner-Jackson; April Favella; Ashley Anderson; Magaly Torres; Kenneth J Ruggiero; Frank A Treiber Journal: J Pers Med Date: 2015-11-17